ESAFETY, TOLERABILITY AND PHARMACODYNAMIC ASSESSMENT OF KAN-101, A NOVEL LIVER-TARGETED THERAPY TO INDUCE IMMUNOLOGICAL TOLERANCE TO GLIADIN IN CELIAC DISEASE

Joseph A. Murray, Karen Dunn, Samir Arora, Peter Winkle,Kaela E. Goldstein,Simon Cooper, Rajesh Manchanda, Stephan Kontos, Kristie M. Grebe

GASTROENTEROLOGY(2022)

引用 0|浏览4
暂无评分
关键词
induce immunological tolerance,liver-targeted
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要